Jianmin Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Jianmin Pharmaceutical Group Co Ltd capital reinvestment ratio. Jianmin Pharmaceutical Group Co Ltd (600976) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥106.82 Million) in capital expenditures (CN¥23.23 Million). Check how aggressively does Jianmin Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Capital reinvestment ratio of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. This chart tracks Jianmin Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 20 annual periods. Also explore Jianmin Pharmaceutical Group Co Ltd (600976) equity growth momentum to track the company's year-over-year net asset growth rate.
Jianmin Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2003–2025)
Jianmin Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see 600976 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | CN¥274.53 Million | CN¥100.67 Million | ▼ -28.6% |
| 2024 | 0.51x | CN¥234.27 Million | CN¥120.29 Million | ▲ +113.7% |
| 2023 | 0.24x | CN¥268.39 Million | CN¥64.50 Million | ▼ -23.7% |
| 2022 | 0.31x | CN¥215.87 Million | CN¥67.96 Million | ▲ +45.7% |
| 2021 | 0.22x | CN¥259.18 Million | CN¥55.99 Million | ▼ -40.5% |
| 2020 | 0.36x | CN¥125.54 Million | CN¥45.58 Million | ▼ -61.0% |
| 2019 | 0.93x | CN¥74.45 Million | CN¥69.31 Million | ▲ +39.8% |
| 2018 | 0.67x | CN¥63.60 Million | CN¥42.37 Million | ▼ -44.1% |
| 2017 | 1.19x | CN¥35.20 Million | CN¥41.93 Million | ▲ +361.0% |
| 2016 | 0.26x | CN¥113.84 Million | CN¥29.42 Million | ▼ -57.9% |
| 2015 | 0.61x | CN¥48.45 Million | CN¥29.75 Million | ▲ +136.8% |
| 2014 | 0.26x | CN¥103.23 Million | CN¥26.77 Million | ▼ -50.8% |
| 2013 | 0.53x | CN¥45.36 Million | CN¥23.90 Million | ▲ +476.8% |
| 2012 | 0.09x | CN¥98.17 Million | CN¥8.97 Million | ▲ +153.3% |
| 2010 | 0.04x | CN¥150.08 Million | CN¥5.41 Million | ▼ -83.4% |
| 2009 | 0.22x | CN¥66.69 Million | CN¥14.50 Million | ▲ +175.5% |
| 2008 | 0.08x | CN¥110.11 Million | CN¥8.69 Million | ▼ -73.3% |
| 2006 | 0.30x | CN¥56.18 Million | CN¥16.61 Million | ▼ -97.9% |
| 2004 | 13.95x | CN¥4.13 Million | CN¥57.64 Million | ▼ -40.3% |
| 2003 | 23.37x | CN¥4.19 Million | CN¥97.88 Million | — |